8.43
price down icon13.36%   -1.30
after-market アフターアワーズ: 8.42 -0.010 -0.12%
loading
前日終値:
$9.73
開ける:
$9.74
24時間の取引高:
592.44K
Relative Volume:
5.12
時価総額:
$145.52M
収益:
$3.25M
当期純損益:
$-116.80M
株価収益率:
-2.7639
EPS:
-3.05
ネットキャッシュフロー:
$-98.17M
1週間 パフォーマンス:
+13.46%
1か月 パフォーマンス:
+7.99%
6か月 パフォーマンス:
-37.65%
1年 パフォーマンス:
-63.54%
1日の値動き範囲:
Value
$8.24
$9.84
1週間の範囲:
Value
$7.04
$9.84
52週間の値動き範囲:
Value
$5.6652
$30.60

Rapt Therapeutics Inc Stock (RAPT) Company Profile

Name
名前
Rapt Therapeutics Inc
Name
セクター
Healthcare (1174)
Name
電話
(650) 489-9000
Name
住所
561 ECCLES AVENUE, SOUTH SAN FRANCISCO, CA
Name
職員
67
Name
Twitter
Name
次回の収益日
2024-11-11
Name
最新のSEC提出書
Name
RAPT's Discussions on Twitter

RAPT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
RAPT
Rapt Therapeutics Inc
8.43 145.52M 3.25M -116.80M -98.17M -3.05
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Rapt Therapeutics Inc Stock (RAPT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-22 再開されました H.C. Wainwright Buy
2024-12-26 アップグレード H.C. Wainwright Neutral → Buy
2024-11-13 ダウングレード Stifel Buy → Hold
2024-11-11 ダウングレード JP Morgan Neutral → Underweight
2024-11-11 ダウングレード Piper Sandler Overweight → Neutral
2024-05-14 ダウングレード Wolfe Research Outperform → Peer Perform
2024-05-10 ダウングレード Barclays Overweight → Equal Weight
2024-05-10 ダウングレード Guggenheim Buy → Neutral
2024-02-22 ダウングレード UBS Buy → Neutral
2024-02-21 ダウングレード H.C. Wainwright Buy → Neutral
2024-02-21 ダウングレード JP Morgan Overweight → Neutral
2024-02-21 ダウングレード Leerink Partners Outperform → Market Perform
2024-02-20 ダウングレード Cantor Fitzgerald Overweight → Neutral
2024-02-16 開始されました Evercore ISI Outperform
2024-02-15 開始されました Wolfe Research Outperform
2023-09-14 開始されました Berenberg Buy
2023-08-09 開始されました Stifel Buy
2023-06-15 開始されました Barclays Overweight
2023-01-04 開始されました Guggenheim Buy
2022-12-01 開始されました Goldman Buy
2022-09-21 開始されました CapitalOne Overweight
2022-05-24 再開されました Cantor Fitzgerald Overweight
2021-12-09 開始されました JP Morgan Overweight
2021-08-12 開始されました SVB Leerink Outperform
2021-06-21 開始されました Piper Sandler Overweight
2020-06-01 開始されました H.C. Wainwright Buy
2020-05-19 開始されました Cantor Fitzgerald Overweight
2020-04-13 開始されました ROTH Capital Buy
2019-11-25 開始されました BMO Capital Markets Outperform
2019-11-25 開始されました UBS Buy
2019-11-25 開始されました Wells Fargo Outperform
すべてを表示

Rapt Therapeutics Inc (RAPT) 最新ニュース

pulisher
Jun 18, 2025

Wall Street Analysts Predict a 282.65% Upside in Rapt Therapeutics (RAPT): Here's What You Should Know - Yahoo Finance

Jun 18, 2025
pulisher
Jun 17, 2025

RAPT Therapeutics Executes 1-for-8 Reverse Stock Split - TipRanks

Jun 17, 2025
pulisher
Jun 16, 2025

RAPT Therapeutics (RAPT) Trading Halted as News Awaits Release | RAPT Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Layoff Tracker: Gilead Cuts 36 Employees in California - BioSpace

Jun 16, 2025
pulisher
Jun 14, 2025

Rapt Therapeutics announces effective date for 1-for-8 reverse stock split - Yahoo Finance

Jun 14, 2025
pulisher
Jun 13, 2025

# RAPT Therapeutics to implement 1-for-8 reverse stock split By Investing.com - Investing.com South Africa

Jun 13, 2025
pulisher
Jun 13, 2025

RAPT Finalizes Reverse Split Plan; 1-for-8 Ratio Effective June 16, 2025 - Nasdaq

Jun 13, 2025
pulisher
Jun 13, 2025

RAPT Therapeutics Shares to Start Trading on a Split-Adjusted Basis Tuesday - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

RAPT Therapeutics Announces Effective Date For 1-For-8 Reverse Stock Split - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

RAPT Therapeutics Announces Reverse Stock Split Effective June 2025 | RAPT Stock News - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

# RAPT Therapeutics to implement 1-for-8 reverse stock split - Investing.com

Jun 13, 2025
pulisher
Jun 13, 2025

RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split - GlobeNewswire

Jun 13, 2025
pulisher
Jun 13, 2025

RAPT Therapeutics Announces Major Share Consolidation: 132M Shares Shrinking to 16.5M in Reverse Split - Stock Titan

Jun 13, 2025
pulisher
Jun 12, 2025

Two Sigma Investments LP Sells 339,957 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

Transcript : RAPT Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 09 - MarketScreener

Jun 10, 2025
pulisher
Jun 09, 2025

Rapt Therapeutics Get A Bullish Recommendation On ‘Significant Opportunity’ For Allergy Drug Candidate: Retail Worries About Cash Position - MSN

Jun 09, 2025
pulisher
Jun 09, 2025

RAPT Therapeutics Announces Development Plans for RPT904 - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

Jane Street Group LLC Sells 29,821 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Nuveen Asset Management LLC Buys 39,216 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

RAPT Therapeutics (RAPT) Has a New Rating from Clear Street - The Globe and Mail

Jun 06, 2025
pulisher
Jun 05, 2025

Rapt Therapeutics Get A Bullish Recommendation On ‘Significant Opportunity’ For Allergy Drug Candidate: Retail Worries About Cash Position By Stocktwits - Investing.com India

Jun 05, 2025
pulisher
Jun 05, 2025

Clear Street initiates Rapt Therapeutics stock with buy rating By Investing.com - Investing.com UK

Jun 05, 2025
pulisher
Jun 05, 2025

Clear Street Initiates Coverage on Rapt Therapeutics (RAPT) with Buy Rating | RAPT Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Millennium Management LLC Sells 222,261 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

RAPT Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Jun 04, 2025
pulisher
Jun 04, 2025

RAPT Therapeutics Management to Share Latest Immunology Pipeline Updates at Major Healthcare Conferences - Stock Titan

Jun 04, 2025
pulisher
Jun 03, 2025

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World

Jun 03, 2025
pulisher
May 28, 2025

RAPT Therapeutics Faces Nasdaq Delisting Notice - TipRanks

May 28, 2025
pulisher
May 26, 2025

What is HC Wainwright’s Forecast for RAPT Q2 Earnings? - Defense World

May 26, 2025
pulisher
May 25, 2025

UBS Group Cuts RAPT Therapeutics (NASDAQ:RAPT) Price Target to $1.00 - Defense World

May 25, 2025
pulisher
May 24, 2025

RAPT Therapeutics (NASDAQ:RAPT) Stock Rating Upgraded by HC Wainwright - Defense World

May 24, 2025
pulisher
May 23, 2025

D. E. Shaw & Co. Inc. Sells 278,173 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World

May 23, 2025
pulisher
May 22, 2025

RAPT Stock: HC Wainwright & Co. Announces New Price Target | RAP - GuruFocus

May 22, 2025
pulisher
May 22, 2025

UBS Adjusts Price Target for Rapt Therapeutics (RAPT) | RAPT Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

RAPT Analyst Update: UBS Adjusts Price Target to $1 | RAPT Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Rapt Therapeutics (RAPT) Receives Buy Rating with Promising Outl - GuruFocus

May 22, 2025
pulisher
May 22, 2025

UBS Adjusts Price Target for Rapt Therapeutics (RAPT) | RAPT Sto - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Rapt Therapeutics (RAPT) Receives Buy Rating with Promising Outlook | RAPT Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

UBS cuts Rapt Therapeutics stock target to $1 from $2 By Investing.com - Investing.com UK

May 22, 2025
pulisher
May 19, 2025

Comerica Bank Purchases Shares of 58,040 RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World

May 19, 2025
pulisher
May 18, 2025

Dimensional Fund Advisors LP Sells 105,231 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World

May 18, 2025
pulisher
May 16, 2025

Rapt Therapeutics (RAPT) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

May 16, 2025
pulisher
May 09, 2025

RAPT Therapeutics, Inc. (RAPT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire

May 09, 2025
pulisher
May 09, 2025

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Given Average Rating of “Hold” by Analysts - Defense World

May 09, 2025
pulisher
May 09, 2025

RAPT Therapeutics Reports Improved Q1 2025 Results - TipRanks

May 09, 2025
pulisher
May 08, 2025

RAPT Therapeutics Reports First Quarter 2025 Financial Results - GlobeNewswire

May 08, 2025
pulisher
May 08, 2025

RAPT Therapeutics, Inc. SEC 10-Q Report - TradingView

May 08, 2025
pulisher
May 05, 2025

RAPT Therapeutics Reports Third Quarter 2024 Financial Results - ADVFN

May 05, 2025
pulisher
May 05, 2025

RAPT Therapeutics Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView

May 05, 2025
pulisher
May 04, 2025

RAPTRapt Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan

May 04, 2025
pulisher
May 04, 2025

Renaissance Technologies LLC Has $584,000 Stock Position in RAPT Therapeutics, Inc. (NASDAQ:RAPT) - Defense World

May 04, 2025

Rapt Therapeutics Inc (RAPT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
大文字化:     |  ボリューム (24 時間):